COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 655: Articles 6541-6550  | Next

Nanobody engineering for SARS-CoV-2 neutralization and detection
Hannula, L., Kuivanen, S., Lasham, J., Kant, R., Kareinen, L., Bogacheva, M., Strandin, T., Sironen, T., Sharma, V., Saviranta, P., Kipar, A., Vapalahti, O., Huiskonen, J. T., Rissanen, I.
10.1101/2022.09.14.507920 — Posted: 2022-09-14
Trans-synaptic dwelling of SARS-CoV-2 particles perturbs neural synapse organization and function
Partiot, E., Hirschler, A., Colomb, S., Lutz, W., Claeys, T., Delalande, F., Deffieu, M. S., Roels, J., Bons, J., Callon, D., Andreoletti, L., Labrousse, M., Jacobs, F. M., Rigau, V., Charlot, B., Martens, L., Carapito, C., Ganesh, G., Gaudin, R.
10.1101/2022.09.13.507484 — Posted: 2022-09-14
Kinase-independent activity of DYRK1A promotes viral entry of highly pathogenic human coronaviruses
Strine, M. S., Cai, W. L., Wei, J., Alfajaro, M. M., Filler, R. B., Biering, S. B., Sarnik, S., Patil, A., Cervantes, K. S., Collings, C. K., DeWeirdt, P. C., Hanna, R. E., Schofield, K., Hulme, C., Konermann, S., Doench, J. G., Hsu, P. D., Kadoch, C., Yan, Q., Wilen, C. B.
10.1101/2022.09.13.507833 — Posted: 2022-09-14
SARS-CoV-2 Protein Nsp2 Stimulates Translation Under Normal and Hypoxic Conditions
Korneeva, N., Khalil, M. I., Ghosh, i., Fan, R., Arnold, T., De Benedetti, A.
10.1101/2022.09.13.507829 — Posted: 2022-09-14
High throughput Bioluminescent assay to characterize and monitor the activity of SARS-CoV-2 Methyltransferases
Hsiao, K., Zegzouti, H., Goueli, S. A.
10.1101/2022.09.12.505486 — Posted: 2022-09-13
IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques
Nelson, C. E., Foreman, T. W., Kauffman, K. D., Sakai, S., Fleegle, J. D., Gomez, F., NIAID/DIR Tuberculosis Imaging Program, , Le Nouen, C., Liu, X., Burdette, T. L., Garza, N. L., Lafont, B. A. P., Brooks, K., Arlehamn, C. S. L., Weiskopf, D., Sette, A., Hickman, H. D., Buchhholz, U. J., Johnson, R. F., Brenchley, J. M., Via, L. E., Barber, D. L.
10.1101/2022.09.13.507852 — Posted: 2022-09-13
Does Vaping Increase the Likelihood of SARS-CoV-2 Infection? Paradoxically Yes and No
Phandthong, R., Wong, M., Song, A., Martinez, T., Talbot, P.
10.1101/2022.09.09.507373 — Posted: 2022-09-13
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
Scheaffer, S. M., Lee, D., Whitener, B., Ying, B., Wu, K., Jani, H., Martin, P., Amato, N. J., Avena, L. E., Berrueta, D. M., Schmidt, S. D., O'Dell, S., Nasir, A., Chuang, G.-Y., Stewart-Jones, G., Koup, R. A., Doria-Rose, N. A., Carfi, A., Elbashir, S. M., Thackray, L. B., Edwards, D. K., Diamond, M. S.
10.1101/2022.09.12.507614 — Posted: 2022-09-13
Monitoring correlates of SARS-CoV-2 infection in cell culture using two-photon microscopy and a novel fluorescent calcium-sensitive dye
Domokos, M., Szalay, G., Cseri, L., Kis, Z., Palyi, B., Foldes, G., Kovacs, N., Fulop, A., Szepesi, A., Hajdrik, P., Csomos, A., Zsembery, A., Kadar, K., Katona, G., Mucsi, Z., Rozsa, B. J., Kovacs, E.
10.1101/2022.09.12.506773 — Posted: 2022-09-13
Comparative multi-OMICS single-cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action
Singh, Y., Schulze-Selting, A., Gabernet, G., Ray, U., Bajaj, R., Ali, M., Loitz, M., Hammer, V., Buena-Atienza, E., Ruschil, C., Huebner, J., Kowarik, M., salker, M., Casadei, N., Nahnsen, S., Kremsner, P., Ossowski, S., Altmann, D. M., Deutsche COVID-19 OMICS Initiative (DeCOI), , Riess, O.
10.1101/2022.09.12.507666 — Posted: 2022-09-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).